On August 1, 2016, liaoning province's GDP ranking was 14, and the growth rate was 2.5%. How was the drug market in the grade hospitals?
The total size of the market in the liaoning provincial level hospital in 2016 was 39.915 billion yuan, up 13.1% from the same period in 2015. From the quarter-on-quarter growth of the quarter, the sales volume in the first three quarters of 2016 had a good growth, falling only slightly in the fourth quarter.
In 2016, the market size and the growth rate of liaoning provincial level hospital
(source: zhongkang CMH)
In terms of the proportion of Chinese and western medicine, the proportion of Chinese medicine has increased by 0.2 points in 2016 compared with 2015. In the first quarter of 2016, the proportion of Chinese medicine in the first quarter of 2016 was lower than in the first quarter, and it increased in the second, third and fourth quarters.
In 2016, the proportion of western drug sales in grade hospitals
(source: zhongkang CMH)
In 2016, the sales volume of TOP100 in liaoning provincial level hospital stood at 18.438 billion yuan, up 15.86 percent from the 2015 TOP100, accounting for 46.19 percent of the overall size of liaoning province. Of the TOP100 varieties, there were 88 chemicals and only 12 were made. In terms of indications, there were 29 varieties of full-body anti-infective drugs, followed by 22 types of cardiovascular drugs. More than 10 varieties of anti-tumor and immune modulators, nervous system drugs, digestive system and metabolic drugs were listed. The TOP10 variety has three seats in the overall anti-infection-resistant drug, with two seats for the nervous system and anti-tumor and immuno-regulating agents. The top priority was sodium chloride injection from the blood and hematopoietic system ($812 million in sales, 2.03 percent); The highest ranking of Chinese medicine was the drug of blood and hematopoietic system, shuanning injection (328 million yuan, 0.82 percent).
2016 liaoning grade hospital TOP100
(source: zhongkang CMH) |
